As the coronavirus that causes COVID-19 spreads in more than 60 countries, the race to develop a vaccine to prevent the illness has taken on new urgency. In a meeting with CEOs of major drug companies this week, President Trump ramped up the pressure, suggesting that vaccines could come to...
accessibility
affordability
coronavirus
covid-19
drugcompanies
equity
global health
health
healthcare policy
pharmaceuticals
public health
research
social justice
taxpayer funding
trump administration
u.s. government
urgency
vaccine
vaccine development
